Infection with Carbapenem-Resistant Enterobacteriaceae (CRE) became an important challenge 19 in health-care settings and a growing concern worldwide. Since infection is preceded by 20 colonization, an understanding of the latter may reduce CRE-infections. We aimed to 21 characterize the gut microbiota after colonization by CRE, assuming that an imbalanced 22 gastrointestinal tract (GIT)-associated microbiota precedes CRE-colonization. 23
have increased markedly [1] . Carbapenem-resistant Enterobacteriaceae (CRE) are highly drug-45 resistant pathogens with a rapidly increasing incidence in a variety of clinical settings [2] . 46
Infections caused by CRE have been associated with increased cost and length of stay as well as 47 frequent treatment failures, and death [2] . There are several known risk factors [2,3], including 48 CRE-carriage in the GIT, since it serves as a source for subsequent clinical infection in 49 approximately 9% of carriers [4] . Moreover, CRE-carriers serve as a major reservoir for its 50 dissemination in healthcare facilities [4, 5] . 51
The complex commensal microbiota that normally colonizes mucosal surfaces in healthy 52 individuals allows colonization resistance and inhibits expansion and domination by antibiotic-53 resistant exogenous bacteria such as Enterobacteriaceae [6, 7] .Microbial dysbiosis may lead to an 54 overgrowth of antibiotic resistant pathogens [8] , which can be calamitous for susceptible 55 patients, resulting in bacteremia and sepsis [9] and is associated with increased risk for 56 transmission due to increased shedding to the environment [10, 11] .
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It is reasonable to assume that alteration of the normal microbiota may be associated with the 58 development of CRE-carriage. Therefore, we aimed to determine the structure of GIT-microbiota 59 in CRE-colonized patients. 60
Materials and Methods

61
Study design and participants 62
The study population was comprised of two control groups (15 healthy adults and 22 63 hospitalized non-CRE-carriers), and one group of CRE-carriers (n=40). Hospitalized adults were 64 recruited from the Division of Internal Medicine at Rambam Health Care Campus (Israel); non-65 hospitalized healthy participants were recruited from the local community, and most likely were 66 not CRE-carriers. Within the hospitalized groups, distinction of CRE-carriage was established 67 upon hospitalization and every other week by routine screening for rectal carriage. 68
The following exclusion criteria were applied to the healthy group to avoid factors capable of 69 altering the microbiome: current smoker, active or recent (6 months) chemotherapy and/or 70 radiation treatment, homeopathic preparations user, currently suffering any infectious disease, 71 chronic or acute gastro intestinal track disease including Clostridium difficile infection, and/or 72 antibiotic treatment or vaccination within the last 6 months prior to sample collection. This group 73 individuals volunteered and were recruited randomly by hospital staff. Nonetheless, due to the 74 lack of antibiotic treatment, difference in participant's average age and the fact they were not 75 hospitalized under similar conditions, the majority of comparative analyses were conducted 76 between the two hospitalized groups.
Page 5
Both hospitalized groups included in this study were hospitalized for at least 7 days at the same 78 healthcare facility. Inclusion criteria included patient hospitalized for at least 7 days, which 79 receive minimum 7 days of antibiotic treatment. 80
Written informed consent was obtained from all study participants. The study was approved by 81 the Rambam Health Care Campus ethics committee (approval number 0418-14-RMB). This 82 study conformed to the Helsinki Declaration and to local legislation. 83
Clinical analyses were performed on the entire study population (n=77), and 55 samples from the 84 three groups were sent for sequencing (the earliest recruits). Clinical variables including medical 85 background, and laboratory parameters were retrieved from medical records (see table 1 and 2). 86
Sample collection 87
Fresh fecal samples were collected from hospitalized participants by the research cadre (CRE-88 carriers and non-carrier groups). Following collection, swabs were stored at -80 º C. Samples from 89 healthy participants were self-collected by participants, and transported in a freezer pack to the 90 laboratory within 24 hours of collection, and then stored at -80 º C. 91
Microbiota sequencing and taxonomy assignment: 92
Total DNA was extracted from the samples using QIAamp Fast 
Microbiota composition and metabolic analysis
Results
Page 8
To study the microbiota profile in CRE-carriage we analyzed the clinical parameters and 142 microbial composition of three groups: hospitalized CRE-carriers, hospitalized non-carriers, and 143 healthy controls. 144
Study cohort clinical characteristics 145
The demographic and clinical characteristics of the study cohort for all groups are presented in 146 Tables 1 and 2. There were no significant differences between the groups regarding confounding 147 factors such as gender, ethnic origin, gastrointestinal disease, radiotherapy, chemotherapy, and 148 diabetes mellitus. Moreover, the comparison between these factors and the microbial profile 149 described below was insignificant. 150
Hospitalized patients were older than the healthy individuals (average ages 68.3 and 42.2, 151 respectively). In general, antibiotic usage (broad vs. narrow spectrum), and positive culture 152 prevalence were similar in both hospitalized groups. However, the rate of bacteremia was twice 153 as high in the CRE-carriers. 154
Regarding antibiotics usage, it was noted that Vancomycin and Tazocin treatments were used 155 more in the CRE-carriers, while Amikacin and Rocephin treatments were used more in the 156 hospitalized non-carriers (Kruskal-Wallis p<0.05). Notably, most comparative analyses 157 conducted between the two hospitalized groups (excluding the healthy group), because of the 158 different age average, the strict exclusion criteria and the lack of antibiotic treatment, which 159 effect the microbiota. 160
The prevalence of positive urine, sputum, and blood cultures (not specifically by CRE) was 161 around 80% and similar between both hospitalized groups. However, a higher bacteremia rate 
Microbiota characterization 169
To characterize the microbiota, participants fecal DNA was subjected to 16S rRNA genes 170 sequencing. 171
Taxonomic classification revealed that the dominant bacterial phyla were Bacteroidetes (56-172 62%), Firmicutes (19-35%), and Proteobacteria (6-21%) ( Fig 1A) . Firmicutes prevalence was 173 significantly lower in the CRE-carriers compared to non-carriers and healthy controls (p<0.005); 174
Proteobacteria were significantly higher in the CRE-carriers (p<0.005). The ratio between 175
Firmicutes to Bacteroidetes, considered highly relevant in human gut microbiota composition, 176 was the lowest in the CRE-carriers (0.35±0.05), higher for hospitalized non-carriers (0.41±0.05), 177 and highest in the healthy group (0.63±0.05). 178 179
Microbial diversity and composition 180
Microbial richness assessment determined using the Shannon index, revealed that CRE-carriers 181 had significantly lower richness as compared to the other groups (p<0.005) ( Fig 1B) . 182
Interestingly, the healthy and non-carriers groups did not differ in the richness measure.
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The bacterial communities of the three groups were compared using weighted UniFrac based on 184 PCoA ( Fig 1C) . The samples from healthy individuals clustered separately from hospitalized 185 participants. The PC1 and PC2 vectors significantly discriminated between the groups (Kruskal-186 Wallis p<0.001). 187
LefSe was used to identify bacterial taxa associated with CRE-carriage, by comparing the 188 microbiota of CRE-carriers and non-carriers (Fig 2A) Fig 2C) , an 193 anaerobic commensals, with potentially important beneficial roles for the host [6,7,12]. The 194 decreased abundance of the Barnesiellaceae family among CRE-carriers, was also significant in 195 analysis of the microbiota with the removal of all OTUs belonging to Enterobacteriaceae family. 196
Functional prediction of the microbiota 197
In this study, we used 16S rRNA genes to study microbial communities in However, this marker gene cannot directly identify metabolic or other functional capabilities of 199 the microorganisms. Nonetheless, PICRUSt is a technique that uses evolutionary modeling to 200 predict metagenomes from 16S data and a reference genome database. We used this nd their 201 correlation with relative abundances of selected bacteria identified by LefSe. 202 We found that CRE-carriers were enriched in functional categories associated with xenobiotics 203 biodegradation and metabolism (L2), and amino benzoate degradation (L3) (LDA=3.03, 2.14 204 respectively; p<0.02; Fig S2) . Moreover, Enterobacteriaceae family positively correlated with Page 11 xenobiotics biodegradation and metabolism (R=0.534; FDR p<0.003). Other functional 206 categories changed in CRE-carriers included reduction in histidine metabolism (L3), elevation in 207 ubiquinone and other terpenoid-quinone biosyntheses (L3), and tryptophan metabolism (L3) (Fig  208   S1 ). 209
Discussion
210
This study has demonstrated that CRE-colonized patients have dysbiotic microbiota in terms of 211 community membership with different functional metabolic microbiota profiles. 212
The intestinal microbiota can protect itself against colonization with new bacteria (colonization 213 resistance), while dysbiosis is exploited, apparently, by CRE for colonization. On the other hand, 214 it is also possible that the established CRE-colonization induce significant perturbations to the 215 microbiota, which in turn may act as a pathogenic community to perpetuate host pathology [13] . 216
We observed that healthy individuals has higher microbial diversity while CRE-carriers has the 217 lowest diversity ( Fig 1B) [14, 15] . Moreover, we observed three clusters indicating different 218 microbial community structure for each of the experimental groups ( Fig 1C) . This is in 219 agreement with numerous studies that have shown reduced bacterial diversity in obesity, 220 inflammatory bowel disease, irritable bowel syndrome, and type-2 diabetes mellitus [14, 15] . 221
Few specific taxa of the microbiota were different between the CRE-carriers and non-carriers. 222
First, in addition to the CRE-itself, we observed increased Enterobacteriaceae abundance 223 (Enterobacter, Erwinia, Pantoea, Klebsiella), among which were resident species with virulence 224 potential that are normally kept at low levels. This consequently predisposes the host to Page 12 infections with life-threatening sequelae caused by the CRE-itself and potentially other 226
pathobionts. 227
Second, concurrently with the bloom in Enterobacteriaceae, a depletion of anaerobic-228 commensals was observed (Fig 2) , among which were Coprococcus and Faecalibacterium 229 abundance, an important short-chain fatty acids (SCFA) producing commensal bacteria [12] . 230
These SCFAs are physiological byproducts of carbohydrate fermentation by the microbiota, and 231 serve to salvage energy for the host, enhance the mucosal barrier, inhibit intestinal inflammation, 232 and oxidative stress [16] . Among the functional consequences of reduction in anaerobic-bacteria, 233 is a reduced metabolic capacity, often exemplified by a decline in SCFAs production. Dysbiosis 234 caused by broad-spectrum antibiotics (e.g. clindamycin, cephalosporins), which in our case can 235 presumably enable CRE-colonization, is commonly associated with low intestinal SCFAs levels 236 [16] . 237
Colonization resistance depends on microbiota diversity, as well as microbial composition. The 238 intestinal microbiota can protect efficiently against colonization by many enteric pathogens. 239 Therefore, it is not surprising that during dysbiosis, intestinal colonization resistance is impaired. 240
Interestingly, it was shown that Barnesiella spp., which in our study was less abundant in CRE-241 carriers as compared to non-carriers, has the ability to restrict the growth of intestinal pathogens, 242 limit colonization with highly antibiotic-resistant bacteria, and is required to prevent expansion 243 of oxygen-tolerant bacteria such as Enterobacteriaceae [6, 7] . 244
As an outcome of dysbiosis, predictions of metabolic function also indicated a profile shift. In 245 CRE-carriers we found changes in abundance of several pathways including increased histidine 246 metabolism, and decreased ubiquinone and other terpenoid-quinone biosynthesis, tryptophan Page 13 metabolism, xenobiotics biodegradation and metabolism, and amino benzoate degradation (Fig  248   S1 ). These metabolic alterations have been previously linked to modulation of the immune 249 system response to pathogens and the adaptive immune system activation [17, 18] , and 250 compromised intestinal epithelial barrier and function, which allow bacterial translocation [6, 19] . 251
Xenobiotics biodegradation and metabolism category, and specifically the aminobenzoate 252 degradation pathway, generate catechol (1,2-dihydroxybenzene), which promotes 253
Enterobacteriaceae growth and virulence [20] . This can explain the enrichment of this pathway 254 ( Fig S1A, S1B) and its positive correlation with Enterobacteriaceae, and may suggest a causative 255 scenario: the change in the microbiota leading to Enterobacteriaceae enrichment. Taken together, 256 the functional prediction of the microbiota leading to enrichment in Enterobacteriaceae, immune 257 system modulation and intestinal epithelial damage, can explain the higher rate of blood-stream 258 infections in the CRE-carrierssince colonization with Enterobacteriaciae has been associated 259 with increased risk for bacteremia [21] . 260
These compositional and functional changes predispose the host to invasive infection and death. 261
We found higher rates of bacteremia (not caused only by CRE) in the CRE-carriers group 262 compared to the non-carriers (Table 1) . Interestingly, only one patient had bacteremia with K. 263 pneumoniae KPC, which is consistent with a previous study showing that K. pneumoniae isolates 264 from blood samples were less likely to harbor KPC [3]. This can be explained by the fitness costs 265 of resistance, typically observed as a reduced bacterial growth rate [22] . 266
It can be assumed that the dysbiotic microbiota and high rate of bacteremia in CRE-carriers is 267 linked by low levels of SCFAs, shown to interact with innate mechanisms of defense against Page 14 infection (regulation of immune cell function by SCFA), and low levels of "defensive bacteria" 269 such as Barnesiella [6, 16] . 270
Once established, the gut microbiota composition is relatively stable throughout adult life, but 271 can alter as a result of the action of several vectors. In our study, a trend towards a statistically 272 significant difference between the experimental groups was found in the following factors: 273 treatment with carbapenem, chemotherapy treatment, and gastrointestinal disease/disorder. 274
However, we cannot point to the exact determinants influencing the microbiota composition in 275 CRE-carriers. Whatever the predominant factors that modify the microbiota are, the end result is 276 an "unhealthy microbiota" which lost "key species" required for shaping a "healthy microbiota." 277 Indeed, gut microbiota has been previously shown to effect susceptibility to infections caused by 278 other pathogens such as Vibrio cholerae [23] , and C. difficile [24] . 279
One major limitation of our study is the strong impact of antibiotic treatment on the gut 280 microbiota [25] . To weaken the effect, one of our control groups was comprised of hospitalized 281 non-CRE-carriers. Both hospitalized groups were hospitalized (for at least seven days) at the 282 same healthcare facility, and were treated with antibiotics profile similar to that of the 283 hospitalized CRE-carriers. As mentioned, no significant confounding factors differed between 284 the CRE-carriers and non-carriers, except for the CRE-carriage itself. There may be other 285 unexamined factors that may cause the microbial differences we found. Moreover, all taxa-286 associated analyses were conducted by excluding the healthy controls (not hospitalized), since 287 the lack of antibiotic treatment does not allow proper comparison between the groups. 288
In addition, on the basis of this study it is not possible to determine causality between dysbiosis 289 and CRE-colonization, as dysbiosis can be both a cause and a result of CRE-colonization. 290
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Conclusions
291
Overall the results in our cohort, indicate that the interrelation between dysbiotic microbiota, its 292 pool of bacterial genes (microbiome), and their expressing functions might weakens the 293 protection and resistance against CRE-colonization and infection and other pathobionts. 294
Therefore, our study supports the possibility of fecal transplantation as a therapeutic strategy for 295 CRE-carriage, a strategy already efficiently used to treat C. difficile recurrent infection [16,26] 296 and studied for eradication of other highly drug-resistant enteric bacteria carriage [7, 27] . 297
Reintroducing specific strains and/or correction of dysbiosis with probiotics or fecal 298 transplantation may potentially lead to colonization resistance restoration [7, 27] . 299 300 Page 16 
